Cord blood is the blood from a baby that remains in the umbilical cord and placenta after birth. Cord blood banks store frozen cord blood until someone who is a genetic match requires a transplant.
Cord blood contains special cells called hematopoietic stem cells. Hematopoietic stem cells are immature cells that can develop into all types of blood cells, such as red blood cells, white blood cells, and platelets.
Hematopoietic stem cells are the same type of blood-forming stem cells present in a bone marrow transplant. They may help treat over 70 types of disease.
During pregnancy, people can decide whether to have a cord blood collection after giving birth. Collecting cord blood is harmless to both the person giving birth and the newborn.
Cord blood banks freeze and store cord blood samples after collection, ready for future use. There are public and private banking options.
This article will look at the pros and cons of cord blood banking. It will also examine the differences between private and public cord blood banks, the costs, and the procedure.
Stem cells from cord blood and bone marrow both give rise to other blood cells. Sometimes, however, stem cells from cord blood can be more medically useful than those from bone marrow.
Some advantages of cord blood banking include the following:
Some disadvantages of cord blood banking include the following:
Donating cord blood to a public bank is free. However, some hospitals may charge a small fee for collection.
Storing cord blood in a private blood bank can be expensive and cost around $1,500$2,500. There are also annual storage fees, which can cost about $125 each year.
People may need to pay for the initial collection kit, processing, and courier service to deliver the cord blood to the bank. This may cost several hundred dollars.
People can store cord blood in a private cord blood bank or donate to a public cord blood bank.
Private cord blood banks store cord blood for use by the child or their family. The parents own the cord blood.
Private banks can offer directed donations or autologous transplants.
Directed donations are stem cells that a cord blood bank stores for a donors relative to use if they have a condition that stem cells may help treat. In these cases, a private bank will sometimes store cord blood for free.
An autologous transplant procedure uses the persons own cord blood stem cells for their transplant.
According to the American College of Obstetricians and Gynecologists, autologous transplants are rare for several reasons. One of these is that people cannot use their own stem cells during treatment for a genetic disease because the stem cells have the same genes that cause the disease.
Also, people cannot use their own stem cells for a blood disease, such as leukemia. Their cord blood stem cells cannot treat their leukemia.
Public cord blood banks collect donated cord blood for use by anyone who needs it. They may use the cord blood for research purposes or discard the donation. Public banks may also offer directed donations.
Public banks own cord blood donations.
The type of transplant from a public bank is an allogeneic transplant. Allogeneic transplants use cord blood stem cells to treat a condition in someone other than the donor. Allogeneic transplants are more common than autologous transplants.
Allogeneic transplants require a good match between the donor and the person receiving the transplant. A good match means that there are certain similarities between both peoples cells.
If there is not a strong enough match, the immune system of the person receiving the transplant may reject the cells, meaning that the transplant will not work.
A paper in the journal Pediatrics lists multiple organizations that state that public donation is preferable to private storage. This is because of the rare cases in which people can use the stem cells they store at a private bank. The exception is if a family member has a condition that a stem cell transplant could treat.
Stem cells from cord blood may be able to treat several types of condition, such as:
If someone decides to donate cord blood, they can talk to their healthcare provider after 28 weeks of pregnancy.
The person will need to:
Before donating to a public bank, donors must undergo a screening process to check for any infections or genetic, blood, or immune system disorders.
During pregnancy, the person will have blood tests, and the cord blood will go through testing after collection.
The collection of cord blood takes place after delivery. A healthcare professional will clamp and cut the umbilical cord. They will then use a needle to draw blood from the umbilical cord and placenta to store in a sterile, sealed bag.
The procedure is painless and straightforward, and it may take around 10 minutes. In some cases, however, the healthcare professional may not be able to collect enough cord blood for a donation.
Also, if there is an emergency during childbirth, healthcare professionals will prioritize the pregnant persons and newborns safety over collecting the cord blood.
When cord blood arrives at the bank, somebody will give it an identifying number and type it, which means that a computer can easily track it to find a match.
Banks freeze the cord blood in a liquid nitrogen freezer and store it until someone needs a transplant.
Cord blood banking can provide stem cells that may treat several conditions, particularly in children and young adults.
People need to decide during pregnancy if they want to donate or store cord blood from their child, and they will need to meet certain criteria.
People can discuss the pros and cons of public or private banking with their doctor, especially if they have an existing family member with a condition who could benefit from stem cell treatment.
Read more:
Cord blood banking: Definitions, pros, and cons - Medical News Today
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
- Experts Explain how MS Impacts the Eyes and Eye Health - Health Central - October 18th, 2023
Recent Comments